Search Results - Jan Stratmann

Blast vacuolization in AML patients indicates adverse-risk AML and is associated with impaired survival after intensive induction chemotherapy. by Olivier Ballo, Jan Stratmann, Hubert Serve, Björn Steffen, Fabian Finkelmeier, Christian Brandts

Get full text

Pulmonary Resection after Radiosurgery and Neoadjuvant Immunochemotherapy for NSCLC Patients with Synchronous Brain Metastasis—A Case Series of Three Patients by Agnes Koch, Stefan Sponholz, Stephan Trainer, Jan Stratmann, Martin Sebastian, Maximilian Rauch, Robert Wolff, Joachim P. Steinbach, Michael W. Ronellenfitsch, Hans Urban

Get full text

Serum metabolomic signatures predict clinical outcomes in advanced non-small cell lung cancer treated with pembrolizumab plus platinum-based chemotherapy by Peter May, Christof Winter, Inga Hubrecht, Adrian Patenge, Selina Strathmeyer, Roland Geyer, Steffen Heelemann, Jan Stratmann, Seyer Safi, Henriette Klein, Folker Schneller, Florian Bassermann, Florian Bassermann, Florian Bassermann, Florian Bassermann, Aaron Becker von Rose

Get full text

Treatment Patterns, Outcome, and Quality of Life of Patients With Extensive-Stage SCLC Receiving Third-Line Therapy—Data From the German CRISP Registry (AIO-TRK-0315): A Brief Repo... by Maximilian Rost, MD, Rieke Fischer, MD, Martin Reck, MD, PhD, Thomas Gauler, MD, PhD, Cornelius Waller, MD, PhD, Petros Christopoulos, MD, PhD, Petra Hoffknecht, MD, Martina Jänicke, PhD, Annette Fleitz, PhD, Andrea Härzschel, PhD, Carolin Lennartz, PhD, Paula Ludwig, MSc, Annika Groth, MD, PhD, Michael Bendel, MD, Jan Stratmann, MD, PhD, Frank Griesinger, MD, PhD, Michael Thomas, MD, PhD, Wilfried E.E. Eberhardt, MD, PhD, Martin Sebastian, MD

Get full text